# Siren Biotechnology receives $8M CIRM grant for AAV gene therapy brain cancer trial

_Published Friday, June 26, 2026 at 10:23 PM EDT · Science · Latest · Tier 2 — Notable_

Siren Biotechnology announced on X on June 26, 2026, that it has been awarded an $8 million non-dilutive CLIN2 grant from the California Institute for Regenerative Medicine.

The grant will support the company's Phase 1/2 clinical trial of SRN-101 in adult patients with recurrent high-grade glioma. The post from the account @SirenBio stated the funding comes from CIRM and thanked the organization along with the support of Californians. The announcement included a link to a press release and used the hashtag #cancer.

The post was made by Siren Biotechnology, Inc.

## Sources

- [SirenBio](https://x.com/SirenBio/status/2070557911160586454)

---
Canonical: https://techandbusiness.org/newswire/X0O85GNlLhBSz1ObTqO1BE
Published: 2026-06-27T02:23:09.847Z
Story chronology: 2026-06-27T12:00:00.000Z
Retrieved: 2026-09-25T18:25:14.282Z
Publisher: Tech & Business (techandbusiness.org)